% alzhub.org topic: glp-1-receptor
% Source: https://alzhub.org/topic/glp-1-receptor
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{kong2023-37771725,
  author  = {Kong, F. and Wu, T. and Dai, J. and Zhai, Z. and Cai, J. and Zhu, Z. and Xu, Y. and Sun, T.},
  title   = {{Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies}},
  journal = {Frontiers in pharmacology},
  year    = {2023},
  doi     = {10.3389/fphar.2023.1205207},
  pmid    = {37771725},
  url     = {https://doi.org/10.3389/fphar.2023.1205207}
}

@article{shu2019-31015047,
  author  = {Shu, X. and Zhang, Y. and Li, M. and Huang, X. and Yang, Y. and Zeng, J. and Zhao, Y. and Wang, X. and others},
  title   = {{Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling}},
  journal = {Neuropharmacology},
  year    = {2019},
  doi     = {10.1016/j.neuropharm.2019.04.018},
  pmid    = {31015047},
  url     = {https://doi.org/10.1016/j.neuropharm.2019.04.018}
}

@article{wang2018-29223528,
  author  = {Wang, Y. and Chen, S. and Xu, Z. and Yao, W. and Gao, X.},
  title   = {{GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling}},
  journal = {Neuropharmacology},
  year    = {2018},
  doi     = {10.1016/j.neuropharm.2017.11.048},
  pmid    = {29223528},
  url     = {https://doi.org/10.1016/j.neuropharm.2017.11.048}
}